journal article·2023-08-09Open access

Ablation of Venous Malformations by Photothermal Therapy with Intravenous Gold Nanoshells

Kathleen Cullion, Claire A. Ostertag-Hill, Michelle Pan, Brian Timko, Elisa Boscolo, Daniel S. Kohane

Nano Letters· Volume 23· Issue 15

Abstract

Venous malformations (VMs) consist of hugely enlarged and dysmorphic veins. These lesions cause significant disfigurement, pain, and complications such as bleeding and coagulopathy. Pharmacotherapy for the treatment of VMs has limited efficacy and potentially limiting toxicity. Current treatment for patients with VMs entails life-long pharmacotherapy or surgical procedures. Here we explored whether intravenously administered agents can be used to destroy VMs by photothermal therapy (PTT), using gold nanoshells (AuNSs) that generated heat following irradiation with near-infrared (NIR) light. In a murine model of VMs, intravenous AuNSs accumulated within the VMs. Irradiation of the VMs induced marked regression and even elimination. Nanoparticle-based photothermal therapy can provide effective therapy for VMs, which are otherwise relatively refractory to treatment.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Vascular Malformations and Hemangiomas · Vascular Malformations Diagnosis and Treatment · Central Venous Catheters and Hemodialysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Laboratory for Biomaterials and Drug Delivery, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts 02115, United States

Department of Medical Critical Care, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts 02115, United States

Department of Surgery, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts 02115, United States

Department of Biomedical Engineering, Tufts University, Medford, Massachusetts 02155, United States

Division of Experiment Hematology and Cancer Biology, Cincinnati Children’s Hospital, Cincinnati, Ohio 45229, United States

Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio 45229, United States

Department of Anesthesiology, Critical Care, and Pain Management, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts 02115, United States

Funding

Boston Children's Hospital · National Heart, Lung, and Blood Institute · National Institute of General Medical Sciences · Stuart and Jane Weitzman Family Vascular Anomalies Fund

References (39)

Show source-provided references
1. Limaye, N.; Vikkula, M. Hemangiomas and Vascular Malformations, An Atlas of Diagnosis and Treatment; 2009; pp 99–108.10.1007/978-88-470-0569-3_13 ↗
2. 10.1001/archfaci.2011.79510.1001/archfaci.2011.795 ↗
3. 10.1016/S0190-9622(97)70284-610.1016/S0190-9622(97)70284-6 ↗
4. 10.1001/archderm.144.7.86110.1001/archderm.144.7.861 ↗
5. 10.1053/j.sempedsurg.2014.06.01510.1053/j.sempedsurg.2014.06.015 ↗
6. 10.1053/j.sempedsurg.2017.09.00710.1053/j.sempedsurg.2017.09.007 ↗
7. 10.1542/peds.2015-325710.1542/peds.2015-3257 ↗
8. 10.1172/JCI7600410.1172/JCI76004 ↗
9. 10.1517/17425247.2014.93043510.1517/17425247.2014.930435 ↗
10. 10.3389/fchem.2019.0016710.3389/fchem.2019.00167 ↗
11. 10.1007/s13530-011-0109-y10.1007/s13530-011-0109-y ↗
12. 10.1073/pnas.190692911610.1073/pnas.1906929116 ↗
13. 10.1007/s13346-022-01232-410.1007/s13346-022-01232-4 ↗
14. 10.1016/j.bbcan.2021.18853210.1016/j.bbcan.2021.188532 ↗
15. 10.1016/j.jconrel.2018.07.03310.1016/j.jconrel.2018.07.033 ↗
16. 10.1007/s10103-017-2317-410.1007/s10103-017-2317-4 ↗
17. 10.1021/jz900366c10.1021/jz900366c ↗
18. 10.1039/C1CS15237H10.1039/C1CS15237H ↗
19. 10.1073/pnas.132265111110.1073/pnas.1322651111 ↗
20. 10.1016/j.nano.2012.11.00210.1016/j.nano.2012.11.002 ↗
21. 10.1016/S0065-2571(00)00013-310.1016/S0065-2571(00)00013-3 ↗
22. 10.1038/s41467-019-08690-410.1038/s41467-019-08690-4 ↗
23. 10.1021/nl903411s10.1021/nl903411s ↗
24. 10.1021/acs.nanolett.1c0202710.1021/acs.nanolett.1c02027 ↗
25. 10.21037/cdt.2016.11.1010.21037/cdt.2016.11.10 ↗
26. 10.1016/j.ajhg.2015.11.01110.1016/j.ajhg.2015.11.011 ↗
27. 10.1093/hmg/ddv34910.1093/hmg/ddv349 ↗
28. 10.1021/acsami.9b1885510.1021/acsami.9b18855 ↗
29. 10.1038/s41598-019-48748-310.1038/s41598-019-48748-3 ↗
30. 10.1073/pnas.131533611010.1073/pnas.1315336110 ↗
31. 10.1021/acs.nanolett.0c0197310.1021/acs.nanolett.0c01973 ↗
32. 10.1021/acs.nanolett.6b0173010.1021/acs.nanolett.6b01730 ↗
33. 10.2217/nnm.11.12510.2217/nnm.11.125 ↗
34. 10.1016/S1074-7613(00)80665-210.1016/S1074-7613(00)80665-2 ↗
35. 10.1016/j.mtbio.2022.10040110.1016/j.mtbio.2022.100401 ↗
36. 10.1177/109158181560017010.1177/1091581815600170 ↗
37. 10.1016/j.jdermsci.2017.12.00910.1016/j.jdermsci.2017.12.009 ↗
38. 10.1038/nri364610.1038/nri3646 ↗
39. 10.3791/61501-v10.3791/61501-v ↗